Miriam Komaromy, MD, DFASAM, FACP

Medical Director, Grayken Center for Addiction

Boston Medical Center, Boston University

Dr. Miriam Komaromy is a physician and Medical Director of Boston Medical Center’s Grayken Center for Addiction.  She is board certified in Internal Medicine and Addiction Medicine.  She leads an NIMH-funded study of how to optimize treatment of opioid use disorder plus co-occurring mental health disorders in primary care settings.  Prior to moving to Boston in 2019, she was Associate Director in the University of New Mexico’s ECHO Institute, leading medical education programs that are focused on treatment of substance use disorders, for the past 13 years.  She has served as Medical Director for New Mexico’s state-funded addiction treatment hospital, and led the development of the state’s guidelines for treatment of opioid use disorder.  Dr. Komaromy is a member of the board of directors of the American Society of Addiction Medicine (ASAM), which is the largest addiction-specialty society in the United States.  She is vice-chair of ASAM’s national medical education committee, and she chairs their Fundamentals of Addiction Medicine committee.  She was recently elected ASAM educator of the year for 2019.  Dr. Komaromy lectures nationally and internationally on addiction medicine topics, including stigma, treatment of opioid use disorder, harm reduction, and how to address the use of amphetamine-type substances.  In 2018-2019 Dr. Komaromy served as a Fulbright Scholar in Hanoi, Vietnam, performing research and providing education on treatment of substance use disorders.